The Washington State Court of Appeal reversed and remanded a product liability suit against Hyland’s Naturals on Monday after determining that the trial court improperly applied the Frye standard to exclude testimony from a doctor who concluded that the company’s tablets “‘more likely than not’” caused the death of a 13-month-old child.
Tanessa Desranleau sued Hyland’s after her son, Jay’Breon Bush Desranleau, died in his crib in January 2014. In the days before his death, Desranleau’s son had a cold, and she gave him “Baby Tiny Cold Tablets,” a homeopathic cold remedy manufactured by the company. The tablets contain Gelsemium sempervirens, a medicinal herb, which Desranleau claims caused her son’s death.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
